Immunogenic Polypeptide Composed of HLA-B7 Restricted Tumor Antigen-Derived Optimized Cryptic Peptides, and Uses Thereof

• 收藏
• 分享

专利权人:

VAXON BIOTECH

发明人:

Catherine Gallou,Jeanne Menez-Jamet

申请号：

US15327244

公开号：

US20170157228A1

申请日:

2015.07.17

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The invention pertains to an optimized chimeric polypeptide for use in HLA-337 cancer patients, which comprises four optimized peptides derived from cryptic tumor epitopes (CEA, TERT, MAGE and HER-2/neu) to enhance their immunogenicity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/